SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Funding of drugs: do vaccines warrant a different approach?
15 references·5 citing·48 second hop
Funding of drugs: do vaccines warrant a different approach? (2008)Funding of drugs: do vaccines warrant a d…The economic impact of SARS: How does the reality match the predictions? (2008)The economic impact of SARS: …Improving uptake of MMR vaccine (2008)Improving uptake of MMR vacci…Precautionary Behavior in Response to Perceived Threat of Pandemic Influenza (2007)Precautionary Behavior in Res…Compulsory vaccination and conscientious or philosophical exemptions: past, present, and future (2006)Compulsory vaccination and co…Quality-Adjusted Life-Years Lack Quality in Pediatric Care: A Critical Review of Published Cost-Utility Studies in Child Health (2005)Quality-Adjusted Life-Years L…Need for differential discounting of costs and health effects in cost effectiveness analyses (2005)Need for differential discoun…Preferences and Willingness to Pay for Health States Prevented by Pneumococcal Conjugate Vaccine (2004)Preferences and Willingness t…Chapter 33 Economic epidemiology and infectious diseases (2000)Chapter 33 Economic epidemiol…Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective (1999)Evaluating the cost-effective…Impact of anti-vaccine movements on pertussis control: the untold story (1998)Impact of anti-vaccine moveme…Saving future lives. A comparison of three discounting models (1997)Saving future lives. A compar…Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations of the Panel …Proportional Discounting of Future Costs and Benefits (1995)Proportional Discounting of F…Anomalies in Intertemporal Choice: Evidence and an Interpretation (1992)Anomalies in Intertemporal Ch…The Social Rate of Discount and The Optimal Rate of Investment (1963)The Social Rate of Discount a…The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness (2016)The Social Value Of Vaccinati…Equity in disease prevention: Vaccines for the older adults – a national workshop, Australia 2014 (2016)Equity in disease prevention:…A Probabilistic Theory for Intertemporal Indifference (2014)A Probabilistic Theory for In…Approved but non-funded vaccines: Accessing individual protection (2013)Approved but non-funded vacci…Public preferences over efficiency, equity and autonomy in vaccination policy: An empirical study (2012)Public preferences over effic…The Economics of Welfare (1933)Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Discounting and decision making in the economic evaluation of health-care technologies (2010)Handleiding voor kostenonderzoek: methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg (2012)UPDATE OF THE DUTCH MANUAL FOR COSTING IN ECONOMIC EVALUATIONS (2012)Globalization and Disease: The Case of SARS (2004)Responding to global infectious disease outbreaks: Lessons from SARS on the role of risk perception, communication and management (2006)Global Health and Foreign Policy (2010)Economic Impact of the 2015 MERS Outbreak on the Republic of Korea's Tourism-Related Industries (2019)Consumer Spending Responses to the COVID-19 Pandemic: An Assessment of Great Britain (2020)EuroQol - a new facility for the measurement of health-related quality of life (1990)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)Recommendations for Reporting Cost-effectiveness Analyses (1996)Variations in population health status: results from a United Kingdom national questionnaire survey (1998)Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge? (2004)Myopia and Inconsistency in Dynamic Utility Maximization (1973)Toward a positive theory of consumer choice (1980)Prospect theory: An analysis of decision under risk (1988)Golden Eggs and Hyperbolic Discounting (1997)Time Discounting and Time Preference: A Critical Review (2002)Construal-level theory of psychological distance. (2010)Risk perceptions and their relation to risk behavior (2004)Meta-analysis of the relationship between risk perception and health behavior: The example of vaccination. (2007)A Meta-Analysis of the Association between Gender and Protective Behaviors in Response to Respiratory Epidemics and Pandemics (2016)The impact of Covid-19, associated behaviours and policies on the UK economy: A computable general equilibrium model (2020)Application of the protection motivation theory for predicting COVID-19 preventive behaviors in Hormozgan, Iran: a cross-sectional study (2021)Individual and Community Risks of Measles and Pertussis Associated With Personal Exemptions to Immunization (2000)Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults11The names and affiliations of the Task Force members are listed on page v of this supplement and at http://www.thecommunityguide.org22Some of this material was published previously in: Shefer A, Briss P, Rodewald L, et al. Improving immunization coverage rates: an evidence-based review of the literature. Epidemiol Rev 1999;20:96–142. (2000)Anti-vaccinationists past and present (2002)Immunization Programs for Infants, Children, Adolescents, and Adults: Clinical Practice Guidelines by the Infectious Diseases Society of America (2009)Addressing the anti-vaccination movement and the role of HCWs (2013)Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument (2019)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Methods for the economic evaluation of health care programmes (1987)Cost-Effectiveness Analyses of Vaccination Programmes (2008)Modelling Methods for Pharmacoeconomics and Health Technology Assessment (2008)Dynamic Transmission Modeling (2012)Quality of life and pharmacoeconomics in clinical trials (1996)Improving Decision Analyses: Parent Preferences (Utility Values) for Pediatric Health Outcomes (2009)Reducing the burden of suffering from eating disorders: Unmet treatment needs, cost of illness, and the quest for cost-effectiveness (2017)International Valuation Protocol for the EQ-5D-Y-3L (2020)On Economic Inequality (1973)Pareto Optimal Redistribution (2002)Instrument Choice in Environmental Policy (2008)Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association (1999)A postmodern Pandora's box: Anti-vaccination misinformation on the Internet (2009)Anti-vaccine activists, Web 2.0, and the postmodern paradigm – An overview of tactics and tropes used online by the anti-vaccination movement (2011)
this work references cited by second hop

References

  • 1996Recommendations of the Panel on Cost-Effectiveness in Health and Medicine2,455 cited
  • 1992Anomalies in Intertemporal Choice: Evidence and an Interpretation2,305 cited
  • 1998Impact of anti-vaccine movements on pertussis control: the untold story749 cited
  • 1963The Social Rate of Discount and The Optimal Rate of Investment657 cited
  • 2008The economic impact of SARS: How does the reality match the predictions?313 cited
  • 2005Quality-Adjusted Life-Years Lack Quality in Pediatric Care: A Critical Review of Published Cost-Utility Studies in Child Health270 cited
  • 2007Precautionary Behavior in Response to Perceived Threat of Pandemic Influenza270 cited
  • 2006Compulsory vaccination and conscientious or philosophical exemptions: past, present, and future267 cited
  • 2005Need for differential discounting of costs and health effects in cost effectiveness analyses225 cited
  • 1999Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective205 cited
  • 2000Chapter 33 Economic epidemiology and infectious diseases187 cited
  • 2004Preferences and Willingness to Pay for Health States Prevented by Pneumococcal Conjugate Vaccine125 cited
  • 1995Proportional Discounting of Future Costs and Benefits69 cited
  • 1997Saving future lives. A comparison of three discounting models

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

61 cited
  • 2008Improving uptake of MMR vaccine56 cited
  • Cited by

    • 2016The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness105 cited
    • 2016Equity in disease prevention: Vaccines for the older adults – a national workshop, Australia 201427 cited
    • 2013Approved but non-funded vaccines: Accessing individual protection22 cited
    • 2012Public preferences over efficiency, equity and autonomy in vaccination policy: An empirical study20 cited
    • 2014A Probabilistic Theory for Intertemporal Indifference0 cited